CHRISTY RIDDLE: Open Payments
NPI 1992835565 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,179 in 52 payments from 14 companies in 2025. Trend: 2023 $662 · 2024 $1,019 · 2025 $1,179
Food & beverage: $1,179
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 15 | $314 |
| Lilly USA, LLC | 7 | $190 |
| Regeneron Healthcare Solutions, Inc. | 5 | $148 |
| UCB, Inc. | 6 | $114 |
| Galderma Laboratories, L.P. | 5 | $98 |
| Botanix SB Inc | 2 | $58 |
| E.R. Squibb & Sons, L.L.C. | 3 | $58 |
| ABBVIE INC. | 2 | $47 |
| Arcutis Biotherapeutics, Inc. | 2 | $43 |
| Janssen Biotech, Inc. | 1 | $27 |
Products named: DUPIXENT, TALTZ, Bimzelx, NEMLUVIO, SOFDRA, Sotyktu, RINVOQ, Zoryve.
Industry payments across TX — which companies pay providers there.
